FDAnews Drug Daily Bulletin

Sanofi’s Shock Therapy Enrages the French

Aug. 14, 2012
A A
Among the major French companies that have triggered protests at home this summer by announcing job cuts, Sanofi stands out for its audacity. France’s biggest drugmaker plans to slash its research and development staff in Toulouse and Montpellier and is shifting its focus across the Atlantic to Cambridge, Mass.
Businessweek